Antimullerian hormone and inhibin B are hormone measures of ovarian function in late reproductive-aged breast cancer survivors - Wikidata - wikimedia - TriplyDB

Antimullerian hormone and inhibin B are hormone measures of ovarian function in late reproductive-aged breast cancer survivors

Antimullerian hormone and inhibin B are hormone measures of ovarian function in late reproductive-aged breast cancer survivors

http://www.wikidata.org/entity/Q33624886

about

Executive summary of the Stages of Reproductive Aging Workshop +10: addressing the unfinished agenda of staging reproductive aging Comparability of antimüllerian hormone levels among commercially available immunoassays Impact of breast cancer on anti-mullerian hormone levels in young women Self-collected dried blood spots as a tool for measuring ovarian reserve in young female cancer survivors AGO Recommendations for Diagnosis and Treatment of Patients with Primary and Metastatic Breast Cancer. Update 2011.Clinical guide to fertility preservation in hematopoietic cell transplant recipients Fertility concerns and preservation strategies in young women with breast cancer.A highly-sensitive anti-Müllerian hormone assay improves analysis of ovarian function following chemotherapy for early breast cancer.Executive summary of the Stages of Reproductive Aging Workshop + 10: addressing the unfinished agenda of staging reproductive aging.Association between self-reported questionnaire data on fertility and results of hormone analyses in women after childhood cancer: a cross-sectional study.Fertility preservation in breast cancer patients.Prechemotherapy antimullerian hormone, age, and body size predict timing of return of ovarian function in young breast cancer patients Changes in plasma müllerian-inhibiting substance and brain-derived neurotrophic factor after chemotherapy in premenopausal women Antral follicle count provides additive information to hormone measures for determining ovarian function in breast cancer survivors.Tamoxifen and ovarian function.The psychosocial impact of interrupted childbearing in long-term female cancer survivors.Fertility preservation and breast cancer: a review A changing perspective: improving access to fertility preservation Chemotherapy-Related Amenorrhea and Menopause in Young Chinese Breast Cancer Patients: Analysis on Incidence, Risk Factors and Serum Hormone Profiles Executive summary of the Stages of Reproductive Aging Workshop + 10: addressing the unfinished agenda of staging reproductive aging.Contraceptive Practices Among Female Cancer Survivors of Reproductive Age.Predicting Ovarian Activity in Women Affected by Early Breast Cancer: A Meta-Analysis-Based Nomogram Chemotherapy-Induced Amenorrhea - An Update Chemotherapy: Impact on Anti-Müllerian Hormone Levels in Breast Carcinoma.Impact of chemotherapy-induced amenorrhea in breast cancer patients: the evaluation of ovarian function by menstrual history and hormonal levels Pretreatment anti-Müllerian hormone predicts for loss of ovarian function after chemotherapy for early breast cancer.Prediction of postchemotherapy ovarian function using markers of ovarian reserve.Pregnancy after breast cancer: if you wish, ma'am.Utility of gonadotropin-releasing hormone agonists for fertility preservation in young breast cancer patients: the benefit remains uncertain.Anti-Müllerian hormone and assessment of ovarian reserve after ovarian toxic treatment: a systematic narrative review.Gonadotrophin-releasing hormone agonists for fertility preservation: unraveling the enigma?Reproductive health and endocrine disruption in women with breast cancer: a pilot study.Impact of tamoxifen therapy on fertility in breast cancer survivors.Developing a post-treatment survivorship care plan to help breast cancer survivors understand their fertility.The utility of anti-Müllerian hormone in the diagnosis and prediction of loss of ovarian function following chemotherapy for early breast cancer.Ovarian function after chemotherapy in young breast cancer survivors.Survivorship, Version 2.2017, NCCN Clinical Practice Guidelines in Oncology.Assessment of ovarian function after chemotherapy in women with early and locally advanced breast cancer from Serbia.Can ovarian reserve assessment predict fertility following breast cancer treatment?Acute onset of ovarian dysfunction in young females after start of cancer treatment.

P2860

Q27026188-2B398165-80E4-4513-A089-8C2CDEB6B9DD Q28388149-7E841BA7-6096-44AA-AE7A-DC795E86F698 Q28392860-6883E0CA-8F85-40C7-9910-F68641979264 Q28396648-097C10B8-0236-4FDA-A4DA-1692082C5E8F Q30318240-86A49285-8D68-42C0-A58F-B10804366AA0 Q33809651-BA606C11-CC50-4B29-A49F-EFCF962BBFD9 Q33814662-D3FE1056-1F48-49D4-8925-D543B1D9FA04 Q34199333-0B1BF181-16F4-49D8-AB45-1CF0CCE6ACB2 Q34255040-F3F0CD1E-2F21-4FDF-9B12-93600A791B7B Q34260350-2F829830-C718-438B-BFCE-FA3DB8882A46 Q34410874-B86B6035-350E-400F-987B-0A97D95B8A56 Q34550633-BB3B0205-D2DD-4CA3-AC93-5BDD70426E92 Q34618818-FC1BEAAD-5182-4D83-9164-4EE85D382BAA Q34709073-B7D2A3EC-135E-43AE-9F5E-C0F226C6F7DA Q34805784-A5BF1FB3-DE35-4B32-A9E1-8C2C1A28EA9B Q35069536-36F40FC1-636F-459C-B669-A7060D2C2C04 Q35106163-EA0280FA-B852-4C22-8340-CDCE07E341B3 Q35580871-4C734145-0265-4CF8-8C06-112C18FB3DB5 Q35814842-F9DB96AB-5221-4C79-9F38-97DC59F795F1 Q35924430-76081405-4AA2-4E8D-83DC-13F01D990B7C Q35983830-9B32D151-3E27-422F-B544-4A911F92DBA7 Q36116355-8AFF331C-EF10-40F4-A3F4-E48D35D8AAC7 Q36295133-53E74CFE-29B5-44F0-8484-6ED127F15F2B Q36708416-6C23E910-FF1F-43F8-BD78-9201C7145AA8 Q36885123-DDA30A9B-CDCC-4897-9D25-D7C1D0789094 Q37253591-A63F64D8-D7C6-40B2-8A25-8A3F07333FF2 Q37519037-C3AA038F-E2F2-4920-9026-ECA97ACB2F4C Q37893531-3F119EA7-9E5D-47F5-9437-C3A4E715D0F3 Q38109554-C52EB1E0-AFA0-4AF6-850A-4B4D38119D4A Q38250303-DC0193AD-7A2E-48E8-BC62-C3AD31FBB63E Q39026680-8E3B1E3F-55C3-4428-ABC3-9F7BB1E9CB16 Q39145376-3DAFEEA7-4349-4367-A940-FEB3334F4C6E Q39153617-AFB96161-F1F8-4793-A929-47B7E9B28F3C Q46795404-A8E056B9-CAAA-41D2-A886-39F54A744D7C Q47097531-44B338D4-6CA2-494F-BCDD-19B2A3E061D0 Q47124589-B24C2CD3-950C-45DC-8A38-0654010A7735 Q47650581-805A5CA8-FF3E-426D-9F38-82A826CD3376 Q48365999-A3B90755-D45E-4491-932E-B3C207680B5D Q48662239-6BFA60E2-F2B4-4087-A7F9-77DBEFDA727A Q51307952-E2099E54-0D62-42FE-8030-EED1E0ACA0E0

P2860

Antimullerian hormone and inhibin B are hormone measures of ovarian function in late reproductive-aged breast cancer survivors

http://www.wikidata.org/entity/Q33624886

description

2010 nî lūn-bûn

@nan

2010 թուականի Փետրուարին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի փետրվարին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Antimullerian hormone and inhi ...... e-aged breast cancer survivors

@ast

Antimullerian hormone and inhi ...... e-aged breast cancer survivors

@en

type

label

Antimullerian hormone and inhi ...... e-aged breast cancer survivors

@ast

Antimullerian hormone and inhi ...... e-aged breast cancer survivors

@en

prefLabel

Antimullerian hormone and inhi ...... e-aged breast cancer survivors

@ast

Antimullerian hormone and inhi ...... e-aged breast cancer survivors

@en

P1433

Q33624886-90379408-598D-4909-98F9-94EA2104C16D

P1476

Q33624886-A74877FC-C5D3-4DB0-8DB1-11DB029EE9FB

P2093

Q33624886-1D03DAD3-320D-4B1B-B56F-CEF0D20A2882

Q33624886-3A5300B3-64D8-442E-8C05-6730CECDF1A0

Q33624886-5586DA58-575A-46FF-9A1E-8957C2CC32EE

Q33624886-55D3A896-FD91-419F-A2FC-F3B2DDAE7779

Q33624886-77FB2048-A612-4A61-9DE4-3909471F799D

Q33624886-A38C5BBE-63D8-45B6-B7DE-638FF2A60A30

Q33624886-C9FB386E-DE3C-409A-A2CE-6B1031AD1257

Q33624886-F3AF5420-8043-4F91-AC19-0B368642D2AF

Q33624886-FA36BD71-FAD0-40F2-8E59-7C2DFC61E6C5

P2860

Q33624886-084C002F-861F-4A7E-BA7A-71FA24FE81CD

Q33624886-1217128E-67BE-473C-9D6E-87DCD9B1556B

Q33624886-2952F1BD-A674-4466-965C-1FE9FAB88ADE

Q33624886-2AA7A913-4102-4DAA-AB61-7AC485FB172F

Q33624886-3286BFA9-684A-4AD5-80ED-1E7479960613

Q33624886-4FFD761B-078A-4F12-B555-3980990111E1

Q33624886-5D5A9AA3-CFF6-4F4F-9380-7B68F3319FF7

Q33624886-5F26B41D-B168-4978-86FE-4CEF69DA042E

Q33624886-73C75A97-E880-4F8D-B0D5-4292C68FAE94

Q33624886-768CC7C7-84C7-4F97-BD6B-DD2410656D7B

P304

Q33624886-FAF67352-D047-4B3D-8466-CC8D1269E6E9

P31

Q33624886-F8C63A2B-0E77-467E-82FF-FB843D2FB332

P356

Q33624886-FE0F59F2-1617-4413-88AB-A3FDD910FA39

P407

Q33624886-7952C1DB-F01F-4A1E-901D-255647AAF3B0

P433

Q33624886-C58790BB-9077-4968-BB7F-88D6C26B9BE5

P478

Q33624886-711E8366-61F3-4F26-973A-DA4475B1B9CF

P577

Q33624886-9575F95C-9F61-470C-9A2B-064A035F0BC7

P5875

Q33624886-8571605D-E563-4CA1-ACB1-D2505FA9C43F

P698

Q33624886-00C2A21A-DE22-432D-9D4F-8E47A3D10B63

P932

Q33624886-558668C1-E624-489F-B37D-96919404FE73

P356

P1433

P1476

Antimullerian hormone and inhi ...... e-aged breast cancer survivors

@en

P2093

Angela DeMichele

http://www.w3.org/2001/XMLSchema#string

Clarisa R Gracia

http://www.w3.org/2001/XMLSchema#string

Corrie Stankiewicz

http://www.w3.org/2001/XMLSchema#string

Ellen W Freeman

http://www.w3.org/2001/XMLSchema#string

H Irene Su

http://www.w3.org/2001/XMLSchema#string

Jamie Green

http://www.w3.org/2001/XMLSchema#string

Jennifer Matro

http://www.w3.org/2001/XMLSchema#string

Luke Velders

http://www.w3.org/2001/XMLSchema#string

Mary D Sammel

http://www.w3.org/2001/XMLSchema#string

P2860

Cancer statistics, 2008

Early menopause in long-term survivors of cancer during adolescence

A pilot study of predictive markers of chemotherapy-related amenorrhea among premenopausal women with early stage breast cancer

A systematic review of tests predicting ovarian reserve and IVF outcome.

Relationship of serum antimüllerian hormone concentration to age at menopause.

Fertility in female cancer survivors: pathophysiology, preservation and the role of ovarian reserve testing.

Predictors of ovarian reserve in young women with breast cancer

Amenorrhea in premenopausal women after adjuvant chemotherapy for breast cancer.

A review of hormonal changes during the menopausal transition: focus on findings from the Melbourne Women's Midlife Health Project.

Anti-mullerian hormone and inhibin B in the definition of ovarian aging and the menopause transition.

P304

592-599

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/CNCR.24746

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

116

http://www.w3.org/2001/XMLSchema#string

P577

2010-02-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

38094733

http://www.w3.org/2001/XMLSchema#string

P698

19918920

http://www.w3.org/2001/XMLSchema#string

P932

2815049

http://www.w3.org/2001/XMLSchema#string